Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Mitchell Edelson
affiliation not provided to SSRN
Contact
affiliation not provided to SSRN
Email
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
39
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
OATH: A Phase II Trial Evaluating the Combination of Onapristone with Anastrozole for Women with Hormone Receptor Positive Endometrial Cancer
Number of pages: 25
Posted: 05 May 2025
Ida Micaily
,
Mark Shahin
, Mitchell Edelson,
Norman G. Rosenblum
,
Ashley Douglas
,
Saveri Bhattacharya
,
Tommy R. Buchanan
,
Tingting Zhan
,
Tarek Sahmoud
,
Elizabeth Burton
,
Avnish Bhatia
and
Russell J. Schilder
Thomas Jefferson University - Sidney Kimmel Cancer Center,
affiliation not provided to SSRN
,
affiliation not provided to SSRN
, Thomas Jefferson University,
affiliation not provided to SSRN
, Johns Hopkins University - Sidney Kimmel Comprehensive Cancer Center,
affiliation not provided to SSRN
, Thomas Jefferson University,
affiliation not provided to SSRN
,
affiliation not provided to SSRN
, Johns Hopkins University - Sidney Kimmel Comprehensive Cancer Center and Thomas Jefferson University
Downloads
39
(1,196,171)
View PDF
Download
Abstract:
Endometrial cancer, Hormone Receptor, Onapristone, Anastrozole
Feedback
